GlassScriptPhysician profile
John Herbert Haines
NPI 1912906496
$5,723.73
in general payments reported to CMS, 2019-2025
23 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $319 · 2021: $776 · 2022: $536 · 2023: $2,300 · 2024: $603 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,032 · Charitable Contribution: $1,700 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.59 |
| Charitable Contribution | $1,700.04 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $1,700.04 | 2023 | |
| Abbvie INC. | $639.57 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $618.10 | 2019-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $468.78 | 2019-2023 | Veritas Vision System, Tecnis Iol, Tecnis Iol |
| Bausch & Lomb Americas INC. | $440.30 | 2023-2025 | Miebo, Xiidra, Scoutpro Osmolarity System |
| Alcon Vision LLC | $256.56 | 2019-2023 | Rocklatan |
| Rxsight INC | $237.52 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Biotissue Holdings INC. | $198.77 | 2019-2021 | |
| Ivantis, INC | $189.90 | 2021 | |
| Oyster Point Pharma, INC. | $174.04 | 2022-2025 | Tyrvaya |
| Allergan, INC. | $139.47 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.82 | 2019-2021 | |
| Horizon Therapeutics Plc | $99.92 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $88.83 | 2019-2021 | |
| Lensar, INC. | $59.43 | 2023-2025 | Lensar Laser System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $55.20 | 2023-2025 | Iyuzeh |
| Sight Sciences, INC. | $55.16 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Astellas Pharma US INC | $48.85 | 2024 | Izervay |
| Aerie Pharmaceuticals, INC. | $41.85 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $36.58 | 2022-2023 | |
| Amgen INC. | $29.47 | 2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $17.59 | 2025 | Purified Cortrophin Gel |
| New World Medical,INC. | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Haines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.